Ensuring Safety of COVID-19 Vaccines: Q&A with Robert Chen

December 12, 2020

Robert Chen, the Scientific Director of Brighton Collaboration, discussed the safety profiles of COVID-19 vaccines with the Coalition for Epidemic Preparedness Innovations (CEPI). To view the article click here.

More News

Request for Review: Acute Intraocular Inflammation Draft Brighton Case Definition

August 25, 2025

Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever

June 2, 2025

Strengthening Vaccine Safety from Outbreaks to Infants: SPEAC at the World Vaccine Congress

May 27, 2025

Lessons Learned from Vaccine Safety Surveillance Efforts

September 3, 2024

Dr. Punnee Pitisuttithum: Engaging community in active vaccine safety surveillance

July 31, 2024

Request for Review: Vaccine Safety Template – IDT Bio Manuscript

July 22, 2024

More NEWS

August 25, 2025August 25, 2025

Request for Review: Acute Intraocular Inflammation Draft Brighton Case Definition

Dear Brighton Collaboration members: SPEAC is developing a new Brighton format case definition for “Acute Intraocular Inflammati...

June 2, 2025June 2, 2025

Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever

Brighton Collaboration Releases New Template for Evaluating VSV-Based Lassa Fever Vaccines The Brighton Collaboration is proud to...

May 27, 2025May 27, 2025

Strengthening Vaccine Safety from Outbreaks to Infants: SPEAC at the World Vaccine Congress

This April, global leaders in immunization, public health, and biotechnology convened in Washington, D.C. for the 2025 World Vacci...

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

© Brighton Collaboration 2023. All rights reserved.